BHF

Brighthouse FinancialB

Nasdaq / Insurance

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

30%

Probability

Target price

$70.00

Analysis reference price unavailable

Analysis 2026-10-01 · RankAlpha Sentiment Codex

Most likely

Base case

45%

Probability

Target price

$51.00

Analysis reference price unavailable

Analysis 2026-10-01 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$34.00

Analysis reference price unavailable

Analysis 2026-10-01 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-10-01

AI commentary

Deal scrutiny, rather than a fresh earnings surprise, dominates the available coverage. Trusted reporting describes a delayed takeover, while the Delaware regulator confirms an ongoing review but gives no timetable. The packet reports an August 17 stock decline without a verified magnitude; no current analyst revisions, options, short-interest, employee or sufficient social data were established. Zero-valued sentiment fields indicate unavailable data, not neutral readings. Delaware regulator Bloomberg reporting

RankAlpha Sentiment Codex - 2026-10-01

Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators; memo remains a monitoring view with limited forward evidence and should not be standard-conviction

Impact

tentative

Confidence

AI events

2026-12-06eventInsurance-regulatory decision on Aquarian mergerHigh impact

The agreed consideration is $70 cash per common share, versus the $49.90 September 30 anchor. Stockholders have approved the merger, but Delaware, New York and Massachusetts insurance approvals remained outstanding in the June 30 filing. Delaware said its review was ongoing and gave no hearing timetable. Approval could close the substantial deal spread; it is not assured. [#10-Q-2026-08-06] SEC filing Delaware regulator

2026-12-06eventExtended merger outside-date riskHigh impact

Company disclosures provide for an extension to December 6, 2026 if the remaining insurance approvals prevent closing by September 6. Further delay, adverse conditions or termination could force a sharp standalone revaluation; the outside date is not itself proof that the merger will terminate. [#SEC-8K-2026-08-05] Company earnings exhibit

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-10-01 • Updated nightlySource: Internal modelMethodology